Parmigiani G, Berry D, Aguilar O
Institute of Statistics and Decision Sciences, Duke University, Durham, NC 27708-0251, USA.
Am J Hum Genet. 1998 Jan;62(1):145-58. doi: 10.1086/301670.
Breast cancer-susceptibility genes BRCA1 and BRCA2 have recently been identified on the human genome. Women who carry a mutation of one of these genes have a greatly increased chance of developing breast and ovarian cancer, and they usually develop the disease at a much younger age, compared with normal individuals. Women can be tested to see whether they are carriers. A woman who undergoes genetic counseling before testing can be told the probabilities that she is a carrier, given her family history. In this paper we develop a model for evaluating the probabilities that a woman is a carrier of a mutation of BRCA1 and BRCA2, on the basis of her family history of breast and ovarian cancer in first- and second-degree relatives. Of special importance are the relationships of the family members with cancer, the ages at onset of the diseases, and the ages of family members who do not have the diseases. This information can be elicited during genetic counseling and prior to genetic testing. The carrier probabilities are obtained from Bayes's rule, by use of family history as the evidence and by use of the mutation prevalences as the prior distribution. In addressing an individual's carrier probabilities, we incorporate uncertainty about some of the key inputs of the model, such as the age-specific incidence of diseases and the overall prevalence of mutations. There is some evidence that other, undiscovered genes may be important in explaining familial breast cancer. Users of the current version of the model should be aware of this limitation. The methodology that we describe can be extended to more than two genes, should data become available about other genes.
乳腺癌易感基因BRCA1和BRCA2最近已在人类基因组中被识别出来。携带这些基因之一发生突变的女性患乳腺癌和卵巢癌的几率大幅增加,而且与正常个体相比,她们通常在更年轻的时候就会患上这种疾病。女性可以接受检测以确定自己是否为携带者。在检测前接受遗传咨询的女性,可以根据其家族病史被告知她是携带者的概率。在本文中,我们基于女性一级和二级亲属的乳腺癌和卵巢癌家族病史,开发了一个模型来评估她是BRCA1和BRCA2基因突变携带者的概率。特别重要的是患有癌症的家庭成员之间的关系、疾病发病年龄以及未患疾病的家庭成员的年龄。这些信息可以在遗传咨询期间和基因检测之前获取。携带者概率是通过使用家族病史作为证据,并使用突变患病率作为先验分布,从贝叶斯法则中获得的。在处理个体的携带者概率时,我们纳入了模型一些关键输入的不确定性,例如疾病的年龄特异性发病率和突变的总体患病率。有证据表明,其他未被发现的基因可能在解释家族性乳腺癌方面很重要。当前版本模型的用户应意识到这一局限性。如果有关于其他基因的数据,我们所描述的方法可以扩展到两个以上的基因。